nice close, page-5

strong watso has been a long suffering shareholder, and has been tempted to buy more, but the trouble is, it has always promised - yet not delivered. once again, the last order that they announced - which was for about $2m, was a great order. i am having trouble accessing the last business update, but from memory, the order was for about $2m, which was great - and it seems that the company which bought the plant, was reallly only using the plant, to treat 10%of what could be treated - if all went well, then one would expect a huge order so that the relevant company would be able to treat all of the available product. no doubt an order for $20m would send emm shares flying.

emm's partner - de noro - funded the cost of a plant to a polish company - but that was announced ages ago - surely that polish company has had time to assess to product - but they certainly are taking time to commit themselves. at the time, i would have thought that de nora's commitment, by funding the trial, was a huge endorsment for the product - but now looking back, the lack of response by the polish company, leaves me wondering - which simply is par for the course, over the years

never the less, the company continues to make sales, but sadly, not enough to make any profits - i hope that changes